Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2019 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).
Sci Rep. 2021 May 13;11(1):10302. doi: 10.1038/s41598-021-89668-5.
Sci Rep. 2021.
PMID: 33986418
Free PMC article.
Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin.
Monroe JD, Hodzic D, Millay MH, Patty BG, Smith ME.
Monroe JD, et al. Among authors: patty bg.
Molecules. 2019 Oct 29;24(21):3889. doi: 10.3390/molecules24213889.
Molecules. 2019.
PMID: 31671767
Free PMC article.
Item in Clipboard
The curcuminoid, EF-24, reduces cisplatin-mediated reactive oxygen species in zebrafish inner ear auditory and vestibular tissues.
Monroe JD, Millay MH, Patty BG, Smith ME.
Monroe JD, et al. Among authors: patty bg.
J Clin Neurosci. 2018 Nov;57:152-156. doi: 10.1016/j.jocn.2018.09.002. Epub 2018 Sep 20.
J Clin Neurosci. 2018.
PMID: 30243600
Free PMC article.
Item in Clipboard
Cite
Cite